Top

Published in:

01-09-2020 | Opioids | Capsule Commentary

Capsule Commentary on Finlay et al., Barriers to Medications for Opioid Use Disorder Among Veterans Involved in the Legal System: a Qualitative Study

Author: Benjamin A. Howell, MD, MPH, MHS

Published in: Journal of General Internal Medicine | Issue 9/2020

Excerpt

People with opioid use disorder (OUD) released from correctional facilities have a high risk of fatal opioid overdose.¹ Medications for opioid use disorder (MOUD) for this population have shown impressive decreases in risk of overdose.² Yet, analysis of practice uptake persistently has shown low rates of VA MOUD prescribing for veterans with OUD involved in the criminal-legal system.³ It is this gap that Finlay et al.’s insightful qualitative study published in this issue of JGIM addresses.⁴ …

Binswanger IA, Blatchford PJ, Mueller SR, Stern MF. Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Ann Intern Med 2013;159(9):592-600.CrossRef

Green TC, Clarke J, Brinkley-Rubinstein L, Marshall BD, Alexander-Scott N, Boss R, Rich JD. Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system. JAMA Psychiatry 2018;75(4):405-7.CrossRef

Finlay AK, Harris AH, Rosenthal J, Blue-Howells J, Clark S, McGuire J, Timko C, Frayne SM, Smelson D, Oliva E, Binswanger I. Receipt of pharmacotherapy for opioid use disorder by justice-involved US Veterans Health Administration patients. Drug Alcohol Depend 2016;160:222-6.CrossRef

Finlay AK, Morse E, Stimmel M, Taylor E, Timko C, Harris AHS, Smelson D, Yu M, Blue-Howells J, Binswanger IA. Barriers to Medications for Opioid Use Disorder Among Veterans Involved in the Legal System: A Qualitative Study. J Gen Intern Med https://doi.org/10.1007/s11606-020-05944-6

Title: Capsule Commentary on Finlay et al., Barriers to Medications for Opioid Use Disorder Among Veterans Involved in the Legal System: a Qualitative Study
Author: Benjamin A. Howell, MD, MPH, MHS
Publication date: 01-09-2020
Publisher: Springer International Publishing
Keywords: Opioids
Opioids
Published in: Journal of General Internal Medicine / Issue 9/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-020-05975-z

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Capsule Commentary on Finlay et al., Barriers to Medications for Opioid Use Disorder Among Veterans Involved in the Legal System: a Qualitative Study

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 9/2020

Nursing Homes, the Pandemic, and Caring Enough

Releasing Migrants from Detention During the Covid-19 Pandemic

American College of Physicians Ethical Guidance for Electronic Patient-Physician Communication: Aligning Expectations

Investment Income of US Nonprofit Hospitals in 2017

Human Papillomavirus Vaccination and Physical and Mental Health Complaints Among Female Students in Secondary Education Institutions in Denmark

Charlson Comorbidity Index Score and Risk of Severe Outcome and Death in Danish COVID-19 Patients

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page